Key terms

About NKTR

Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology. The firm focuses on using new chemistry approaches to make medicines to treat cancer and autoimmune diseases. The company was founded in 1990 and is headquartered in San Francisco, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest NKTR news

Apr 05 10:40am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 07 4:55am ET Nektar management to meet with Oppenheimer by TipRanks Mar 07 1:00am ET Nektar Therapeutics Is Worried About This – Should You Be Worried Too? by TipRanks Mar 06 11:12am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 05 9:40pm ET Nektar management to meet with Oppenheimer by TipRanks Mar 05 9:09am ET Nektar initiates Phase 2b clinical study of alopecia areata candidate by TipRanks Mar 04 4:16pm ET Nektar reports Q4 EPS (22c), consensus (21c) by TipRanks Mar 04 3:11pm ET Nektar options imply 26.2% move in share price post-earnings by TipRanks Mar 04 8:41am ET Nektar sells 25M shares at $1.20 in private placement by TipRanks Mar 04 7:36am ET Y-mAbs Therapeutics appoints Tagliaferri to board of directors by TipRanks

No recent news articles are available for NKTR

No recent press releases are available for NKTR

NKTR Financials

1-year income & revenue

Key terms

NKTR Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

NKTR Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel